Final results of the randomized phase II VOLFI trial (AIO- KRK0109): mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer (mCRC)
作者
Michael Geißler,Andrea Tannapfel,Anke Reinacher‐Schick,Uwe M. Martens,Jens Ricke,J. Riera-Knorrenschield,Stephan Kanzler,Swantje Held,Volker Heinemann,Thomas Theodor Werner Seufferlein,Dominik Paul Modest
出处
期刊：Annals of Oncology [Elsevier BV] 日期：2019-07-01卷期号：30: iv119-iv120被引量：1
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
OK
Magic
DW
null
Nole
秋风
吃葡萄不吐葡萄皮
周周
壮观雁易
04d
v0id
初景
帅气碧萱
学术雷锋
sagitar
畔畔
一只鱼
aaaa
yuchuncheng
皖公网安备34019202002308
